In the tumor microenvironment across various cancer types, IL-6/JAK/STAT3 signaling promotes tumor cell growth, survival, invasiveness, and metastasis, while significantly suppressing the antitumor immune response [74] (Figure 1). This evidence concerns the gene IL6 and neoplasm.